Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults. Pediatr Blood Cancer 2019 Jul;66(7):e27660
Date
02/14/2019Pubmed ID
30756484Pubmed Central ID
PMC6777708DOI
10.1002/pbc.27660Scopus ID
2-s2.0-85061565177 (requires institutional sign-in at Scopus site) 90 CitationsAbstract
The financial impact of cancer treatment among adolescents and young adults (AYAs, 15-39 years) is deep and long lasting. Compared with other age groups, because of their life stage, AYAs are particularly vulnerable to the adverse economic effects of cancer treatment, also known as financial toxicity. Clinical manifestations of cancer-related financial toxicity include interrupted work and income loss, accumulated debt, treatment nonadherence, avoidance of medical care, and social isolation. Effective clinical interventions should include efforts to increase financial self-efficacy as well as direct support. Measures that are valid, reliable, multidimensional, and age-appropriate are needed to study and address financial toxicity in the AYA population.
Author List
Salsman JM, Bingen K, Barr RD, Freyer DRAuthor
Kristin M. Bingen PhD Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdolescentAdult
Costs and Cost Analysis
Female
Humans
Income
Male
Neoplasms
Young Adult
